The Mkk2 MAPKK Regulates Cell Wall Biogenesis in Cooperation with the Cek1-Pathway in Candida albicans

Elvira Román1, Rebeca Alonso-Monge1, Alberto Miranda1

  • 1Departamento de Microbiología II, Facultad de Farmacia, Universidad Complutense de Madrid, Plaza de Ramón y Cajal s/n, E-28040 Madrid, Spain.

Plos One
|July 22, 2015
PubMed

Insights

The MKK2 gene deletion in Candida albicans impacts cell wall integrity by altering MAPK phosphorylation and gene expression. However, Mkk2 does not influence fungal virulence in infection models.

Area of Science:

  • Mycology
  • Molecular Biology
  • Cell Biology

Background:

  • The cell wall integrity pathway (CWI) is crucial for fungal cell wall biogenesis.
  • Candida albicans is an opportunistic fungal pathogen where CWI is essential.

Purpose of the Study:

  • To investigate the role of the MKK2 gene, encoding a MAPKK in the CWI pathway, in Candida albicans.
  • To characterize the phenotypes of MKK2 deletion mutants and their response to stress.

Main Methods:

  • Gene deletion of MKK2 in different Candida albicans backgrounds.
  • Phenotypic characterization of resultant mutants.
  • Analysis of MAPK phosphorylation patterns and gene expression under various stress conditions.

Main Results:

  • Mkk2 mediates Mkc1 MAPK phosphorylation in response to cell wall stress (zymolyase, tunicamycin) and oxidative stress.
  • mkk2 and mkc1 mutants exhibit distinct cell wall phenotypes and differential MAPK phosphorylation patterns.
  • Altered expression of GSC1, CEK1, and CRH11 genes observed in mkk2 and mkc1 mutants at different temperatures.
  • Combined deletion of MKK2 and HST7 suggests a cooperative role in cell wall architecture.

Conclusions:

  • Mkk2 is a key component of the CWI pathway in Candida albicans, regulating Mkc1 phosphorylation and gene expression.
  • While Mkk2 influences cell wall integrity, it does not appear to play a significant role in Candida albicans virulence.

Related Concept Videos

Role of Microtubules in Cell Wall Deposition01:02

Role of Microtubules in Cell Wall Deposition

Microtubules are small hollow tubes in eukaryotic cells. The cell wall microtubules are polymerized dimers of two globular proteins, α-tubulin and β-tubulin, two globular proteins. With a diameter of about 25 nm, microtubules are the widest components of the cytoskeleton. They help the cell resist compression and provide a track along which vesicles move through the cell or pull replicated chromosomes to opposite ends of a dividing cell. Microtubules go through quick cycles of...
3.4K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.8K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K